(Alliance News) - Markets in Europe got a boost on Wednesday, ahead of two key interest rate decisions, starting with the US Federal Reserve this evening. Read More
(Alliance News) - Stock prices in London were higher heading into Wednesday afternoon, with gains on the FTSE 100 largely broad-based, though a guidance hike could not push GSK into the green. Read More
(Alliance News) - Drugmaker GSK PLC raised its annual outlook on the back of second-quarter revenue growth, but its Vaccines offering struggled, taking some shine out of its earnings. Read More
(Alliance News) - GSK PLC on Wednesday raised its annual guidance after a strong second quarter but shares fell on a lowered outlook for its Vaccines arm and disappointing Shingrix sales. Read More
(Alliance News) - London's FTSE 100 is called to open higher on Wednesday, shaking off a poor day for US tech, ahead of a Federal Reserve interest rate decision. Read More
(Alliance News) - GSK PLC on Monday said its Arexvy offering received a "positive opinion" from the European Medicines Agency's Committee for Medicinal Products for Human Use. Read More
(Alliance News) - London's FTSE 100 is called to open higher on Monday, ahead of a trio of central bank decisions and more US earnings, including numbers from the likes of Apple and Microsoft. Read More
(Alliance News) - GSK PLC on Tuesday reported "positive" data for testing on three different treatments by ViiV Healthcare, its majority-owned specialist HIV company. Read More
(Alliance News) - The FTSE 100 opened higher in London on Friday morning, while other stocks remained downbeat, as a nationwide tech outage combined with gloomy retail sales data at the start of the day. Read More
(Alliance News) - GSK PLC on Friday said its treatment for relapsed or refractory multiple myeloma has been accepted for review by a European regulatory panel. Read More
(Alliance News) - Pharmaceutical company GSK PLC is set to move its global headquarters back to central London, ending more than two decades at its Brentford base. Read More
(Alliance News) - GSK PLC on Wednesday restructured an existing collaboration with CureVac NV into a new licensing agreement to take control of developing a number of flu and Covid drugs. Read More
GSK PLC - London based pharmaceuticals company - Reaches confidential settlement with Martin Gross resolving the case he filed in Illinois state court regarding Zantac. GSK does not admit any liability in this settlement. The case will now be dismissed as to GSK. Continues to vigorously defend itself and manage this litigation in the best interests of the company and shareholders. Read More
